Logo
Logo


ISSN: 0300-9041
ISSNe: 2594-2034


Indizada en: SciELO, Índice Médico Latinoamericano, LILACS, Medline
Editada por la Federación Mexicana de Colegios de Obstetricia, y Ginecologia AC
Fundada por la Asociación Mexicana de Ginecología y Obstetricia en 1945
 

INFORMACIÓN EXCLUSIVA PARA LOS PROFESIONALES DE LA SALUD


Periodicidad: continua
Abreviatura: Ginecol Obstet Mex
ISSN: 0300-9041
ISSNe: 2594-2034
Indizada en: Scimago, Índice Médico Latinoamericano, Lilacs, Medline, Science Citation Index, Ulrich, Ebsco.

Diferencia en el índice neutrófilos-linfocitos entre pacientes con síndrome de ovario poliquístico y sanas

Difference in neutrophil/lymphocyte index between patients with polycystic ovarian syndrome and healthy women.

Ginecol Obstet Mex. 2019 diciembre;87(12):802-806.

https://doi.org/10.24245/gom.v87i12.3439

Sebastián Carranza-Lira,1 Grecia Carmín Rodríguez-Acosta,2 Luis Claudio Erick Hernández-Ángeles3

1 División de Investigación en Salud.
2 Residente de cuarto año de Ginecología y Obstetricia.
3 Servicio de Ginecología Endocrina.
Unidad Médica de Alta Especialidad, Hospital de Ginecoobstetricia 4, Luis Castelazo Ayala, Ciudad de México.


Corrrespondencia:

Sebastián Carranza Lira
drsebastiancarranza@gmail.com

Debe citarse como:

Carranza-Lira S, Rodríguez-Acosta GC, Hernández-Ángeles LCE. Diferencia en el índice neutrófilos-linfocitos entre pacientes con síndrome de ovario poliquístico y mujeres sanas. Ginecol Obstet Mex. 2020 diciembre;87(12):802-806. https://doi.org/10.24245/gom.v87i12.3439

Resumen

OBJETIVO: Determinar la correlación del índice neutrófilos-linfocitos entre mujeres sanas y con síndrome de ovario poliquístico con las concentraciones de glucosa, lípidos y andrógenos.

MATERIALES Y MÉTODOS: Estudio descriptivo, retrospectivo, transversal y comparativo efectuado en el Hospital de Gineco-Obstetricia Luis Castelazo Ayala, entre julio de 2016 y febrero de 2019. Se estudiaron mujeres con síndrome de ovario poliquístico en quienes se cuantificaron: glucosa, lípidos, testosterona, androstenediona y sulfato de dehidroepiandrosterona. Con base en el reporte de la biometría hemática se calculó el índice neutrófilos-linfocitos. Los resultados se compararon con controles sanas estudiadas por infertilidad. Para el análisis estadístico se utilizó U de Mann-Whitney y análisis de correlación de Spearman.

RESULTADOS: Se estudiaron 112 pacientes que se dividieron en dos grupos: el grupo 1 con síndrome de ovario poliquístico (n = 63) y grupo 2 mujeres sanas (n = 49). La mediana de la edad del grupo 1 fue 27 (14-39) la del grupo 2: 28 (16-41) años, sin diferencia estadísticamente significativa entre ambos ni entre los grupos en concentraciones de glucosa, colesterol y triglicéridos. El índice neutrófilos-linfocitos fue significativamente mayor en el grupo con síndrome de ovario poliquístico: 1.9 (0.9-7.4) vs 1.4 (0.8-3.9), p < 0.000, respectivamente.

CONCLUSIÓN: El síndrome de ovario poliquístico se asocia con un proceso inflamatorio crónico y mayor riesgo cardiovascular.

PALABRAS CLAVE: Índice neutrófilos-linfocitos; glucosa; lípidos; enfermedades cardiovasculares; factores de riesgo; androstenediona.

Abstract

OBJECTIVE: To determine the difference in the neutrophil/lymphocyte index between PCOS patients and healthy women.

MATERIALS AND METHODS: Descriptive, retrospective, cross-sectional, comparative study. Women with PCOS were studied in which glucose, lipids, testosterone, androstenedione and dehydroepiandrosterone sulfate were measured, also a blood count was performed, and the neutrophil/lymphocyte index was calculated. The results were compared with healthy controls studied for infertility. For statistical analysis, Mann-Whitney U and Spearman correlation analysis were used.

RESULTS: 112 patients divided as follows were studied: group I with PCOS (n = 63) and group II healthy women (n = 49). The median age was for group I: 27 (14-39) and group II: 28 (16-41) years without statistically significant difference between them, also there were not between the groups in the concentrations of glucose, cholesterol and triglycerides. The neutrophil/lymphocyte index was significantly higher in the group with PCOS, 1.9 (0.9-7.4) vs 1.4 (0.8-3.9), p < 0.000, respectively.

CONCLUSION: PCOS is associated with a chronic inflammatory process that may confer greater cardiovascular risk.

KEYWORDS: Neutrophil/lymphocyte index; Glucose; Lipids; Cardiovascular diseases; Risk factors; Androstenedione.

    1. Azziz R, et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004;89(6):2745-9. doi: 10.1210/jc.2003-032046
    2. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81 (1):19-25. doi: 10.1016/j.fertnstert.2003.10.004
    3. Dahan MH, Reaven G. Relationship among obesity, insulin resistance, and hyperinsulinemia in the polycystic ovary syndrome. Endocrine. 2019 Mar 21. doi: 10.1007/s12020-019-01899-9.
    4. Harris HR, et al. Long and irregular menstrual cycles, polycystic ovary syndrome, and ovarian cancer risk in a population-based case-control study. Int J Cancer. 2017; 140 (2): 285-91. doi: 10.1002/ijc.30441.
    5. Teede HJ, et al. International PCOS Network. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril 2018; 110 (3): 364-79. doi: 10.1016/j.fertnstert.2018.05.004
    6. Kim JJ, et al. Polycystic ovary syndrome with hyperandrogenism as a risk factor for non-obese non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2017; 45 (11): 1403-12. doi: 10.1111/apt.14058
    7. Pant S, et al. Inflammation and atherosclerosis--revisited. J Cardiovasc Pharmacol Ther 2014; 19 (2): 170-8. doi: 10.1177/1074248413504994
    8. Orio F Jr, et al. The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome. J Clin Endocrinol Metab 2005; 90 (1): 2-5. doi: 10.1210/jc.2004-0628
    9. Shi Y, et al. White blood cell differential counts in patients with polycystic ovary syndrome: a pilot study on Chinese women. Eur J Obstet Gynecol Reprod Biol 2013; 170 (1): 162-4. doi: 10.1016/j.ejogrb.2013.06.002
    10. Benson S, et al. Obesity, depression, and chronic low-grade inflammation in women with polycystic ovary syndrome. Brain Behav Immun. 2008; 22 (2): 177-84. doi: 10.1016/j.bbi.2007.07.003
    11. Yu JY, et al. Relationship between inflammatory markers and visceral obesity in obese and overweight Korean adults: An observational study. Medicine (Baltimore) 2019; 98 (9): e14740. doi: 10.1097/MD.0000000000014740
    12. Tsai JC, et al. Association of peripheral total and differential leukocyte counts with metabolic syndrome and risk of ischemic cardiovascular diseases in patients with type 2 diabetes mellitus. Diabetes Metab Res Rev. 2007; 23 (2): 111-8. doi: 10.1002/dmrr.647
    13. Furuncuoğlu Y, et al. How obesity affects the neutrophil/lymphocyte and platelet/lymphocyte ratio, systemic immune-inflammatory index and platelet indices: a retrospective study. Eur Rev Med Pharmacol Sci. 2016; 20: 1300-6. http://europepmc.org/abstract/MED/27097950
    14. Aydin M, et al. Neutrophil/lymphocyte ratio in obese adolescents. North Clin Istanb. 2015; 2 (2): 87-91. DOI: 10.14744/nci.2015.25238
    15. Yilmaz MA, et al. The mean platelet volume and neutrophil to lymphocyte ratio in obese and lean patients with polycystic ovary syndrome. J Endocrinol Invest 2016; 39: 45-53. https://doi.org/10.1007/s40618-015-0335-2

Comentarios